Hyaluronic acid is the main polysaccharide present in the connective tissue. Besides its structural function as backbone of the extracellular matrix, hyaluronic acid plays staple roles in several biological processes including the modulation of inflammation and wound healing processes. The application of hyaluronic acid in regenerative medicine, either as cells and/or drug/growth factors delivery vehicles, relies on its ability to be cross-linked using a plethora of reactions, producing stable hydrogels. In this work, we propose a novel method for the production of hyaluronic acid microparticles that presents several advantages over others that have been used. Basically, droplets of hyaluronic acid solution produced with a nozzle are collected in an isopropanol dehydration bath, and stabilized after crosslinking with adipic acid dihydrazide, using a cabodiimide-based chemistry. The size and morphology of the hyaluronic acid microparticles produced by this method varied with the molecular weight and concentration of the hyaluronic acid solution, the nozzle chamber pressure, the distance between the nozzle and the crosslinking solution, and the number of crosslinking steps. The degree of crosslinking of the hyaluronic acid microparticles produced was tunable and allowed to control the rate of the degradation promoted by hyaluronidase. Moreover, the particles were loaded with platelet lysate, a hemoderivative rich in cytokines with interest for regenerative medicine applications. The hyaluronic acid microparticles showed potential to bind selectively to positively charged molecules, as the factors present in the platelet lysate. It is envisioned that these can be further released in a sustained manner by ion exchange or by the degradation of the hyaluronic acid microparticles matrix promoted by extracellular matrix remodeling.
JiangDLiangJNoblePW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol2007; 23: 435–461.
4.
TooleBPYuQUnderhillCB. Hyaluronan and hyaluronan-binding proteins. Probes for specific detection. Meth Molecul Biol2001; 171: 479–485.
5.
MeyerKPalmerJW. The polysaccharide of the vitreous humor. J Biol Chem1934; 107: 629–634.
6.
FraserJRELaurentTCLaurentUBG. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med1997; 242: 27–33.
7.
ChenWYJAbatangeloG. Functions of hyaluronan in wound repair. Wound Repair Regen1999; 7: 79–89.
8.
EntwistleJHallCLTurleyEA. Receptors: regulators of signalling to the cytoskeleton. J Cell Biochem1996; 61: 569–577.
9.
GerdinBHallgrenR. Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation. J Intern Med1997; 242: 49–55.
10.
WestDCHampsonINArnoldF. Angiogenesis induced by degradation products of hyaluronic-acid. Science1985; 228: 1324–1326.
11.
TooleBP. Hyaluronan in morphogenesis. J Intern Med1997; 242: 35–40.
12.
MenzelEJFarrC. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett1998; 131: 3–11.
13.
CampocciaDDohertyPRadiceM. Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials1998; 19: 2101–2127.
14.
PrestwichGDMarecakDMMarecekJF. Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives. J Control Release1998; 53: 93–103.
15.
YunYHGoetzDJYellenP. Hyaluronan microparticles for sustained gene delivery and site-specific targeting. Biomaterials2004; 25: 147–157.
16.
VercruysseKPMarecakDMMarecekJF. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid. Bioconj Chem1997; 8: 686–694.
17.
LarsenNEPollakCTReinerK. Hylan gel for soft-tissue augmentation, New York, NY: Plenum Press Div Plenum Publishing Corp, 1994, pp. 25–33.
18.
BurdickJAChungCJiaXQ. Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules2005; 6: 386–391.
19.
BergmanKEngstrandTHilbornJ. Injectable cell-free template for bone-tissue formation. J Biomed Mater Res A2009; 91A: 1111–1118.
20.
ZavanBVindigniVVezzuK. Hyaluronan based porous nano-particles enriched with growth factors for the treatment of ulcers: a placebo-controlled study. J Mater Sci Mater Med2009; 20: 235–247.
21.
EspositoEMenegattiECortesiR. Hyaluronan-based microparticles as tools for drug delivery: a comparative study. Int J Pharmaceut2005; 288: 35–49.
22.
MatsuiMTabataY. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels. Acta Biomater2012; 8: 1792–1801.
23.
SipeJBZhangJWaitsC. Localization of bone morphogenetic proteins (BMPs)-2, -4, and -6 within megakaryocytes and platelets. Bone2004; 35: 1316–1322.
24.
KiuruJViinikkaLMyllylaG. Cytoskeleton-dependent release of human platelet epidermal growth factor. Life Sci1991; 49: 1997–2003.
25.
KuritaJMiyamotoMIshiiY. Enhanced vascularization by controlled release of platelet-rich plasma impregnated in biodegradable gelatin hydrogel. Ann Thoracic Surg2011; 92: 837–44. discussion 44.
26.
PhippsMCXuYBellisSL. Delivery of platelet-derived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds. PloS ONE2012; 7: e40831.
27.
SchallmoserKBartmannCRohdeE. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion2007; 47: 1436–1446.
28.
Van PhamPBuiKHNgoDQ. Activated platelet-rich plasma improves adipose-derived stem cell transplantation efficiency in injured articular cartilage. Stem Cell Res Ther2013; 4: 91.
SantoVEDuarteARCPopaEG. Enhancement of osteogenic differentiation of human adipose derived stem cells by the controlled release of platelet lysates from hybrid scaffolds produced by supercritical fluid foaming. J Control Release2012; 162: 19–27.
31.
ChevallierNAnagnostouFZilberS. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials2010; 31: 270–278.
32.
ChenFMAnYZhangR. New insights into and novel applications of release technology for periodontal reconstructive therapies. J Control Release: official journal of the Controlled Release Society2011; 149: 92–110.
33.
SantoVEGomesMEManoJF. Chitosan-chondroitin sulphate nanoparticles for controlled delivery of platelet lysates in bone regenerative medicine. J Tissue Eng Regen Med2012; 6: s47–s59.
34.
Crespo-DiazRBehfarAButlerGW. Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplant2011; 20: 797–811.
35.
BaboPSantoVEDuarteARC. Platelet lysate membranes as new autologous templates for tissue engineering applications. Inflamm Regen2014; 34: 33–44.
36.
YeoYHighleyCBBellasE. In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model. Biomaterials2006; 27: 4698–4705.
37.
DahlmannJKrauseAMollerL. Fully defined in situ cross-linkable alginate and hyaluronic acid hydrogels for myocardial tissue engineering. Biomaterials2013; 34: 940–951.
38.
Fras ZemljicLStana-KleinschekKRibitschV. Quantitative determination of carboxyl groups in cellulose polymers utilizing their ion exchange capacity and using a complexometric titration. Mater Res Innovat2004; 38: 145–146.
39.
YukselenYKayaA. Suitability of the methylene blue test for surface area, cation exchange capacity and swell potential determination of clayey soils. Eng Geol2008; 102: 38–45.
40.
ElsonLAMorganWT. A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J1933; 27: 1824–1828.
41.
ReissigJLStormingerJLLeloirLF. A modified colorimetric method for the estimation of N-acetylamino sugars. J Biol Chem1955; 217: 959–966.
42.
KorsmeyerRWGurnyRDoelkerE. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharmaceut1983; 15: 25–35.
43.
KimHFassihiR. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J Pharmaceut Sci1997; 86: 323–328.
44.
LimSTMartinGPBerryDJ. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microparticles of hyaluronic acid and chitosan. J Control Release: official journal of the Controlled Release Society2000; 66: 281–292.
45.
HuhYChoHJYoonIS. Preparation and evaluation of spray-dried hyaluronic acid microparticles for intranasal delivery of fexofenadine hydrochloride. Eur J Pharmaceut Sci: official journal of the European Federation for Pharmaceutical Sciences2010; 40: 9–15.
46.
CampocciaDHuntJADohertyPJ. Quantitative assessment of the tissue response to films of hyaluronan derivatives. Biomaterials1996; 17: 963–975.
47.
NastruzziCEspositoECortesiR. Kinetics of bromocriptine release from microparticles: comparative analysis between different in vitro models. J Microencapsul1994; 11: 565–574.
48.
MilellaEBresciaEMassaroC. Physico-chemical properties and degradability of non-woven hyaluronan benzylic esters as tissue engineering scaffolds. Biomaterials2002; 23: 1053–1063.
49.
BolletAJBonnerWMJrNanceJL. The presence of hyaluronidase in various mammalian tissues. J Biol Chem1963; 238: 3522–3527.
50.
KucurMKaradagBIsmanFK. Plasma hyaluronidase activity as an indicator of atherosclerosis in patients with coronary artery disease. Bratislavske lekarske listy2009; 110: 21–26.
51.
HiltunenELAnttilaMKulttiA. Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors. Cancer Res2002; 62: 6410–6413.
52.
MeyerKDubosRSmythEM. The hydrolysis of the polysaccharide acids of vitreous humor, of umbilical cord, and of streptococcus by the autolytic enzyme of pneumococcus. J Biol Chem1937; 118: 71–78.
53.
LinkDPvan den DolderJJurgensWJ. Mechanical evaluation of implanted calcium phosphate cement incorporated with PLGA microparticles. Biomaterials2006; 27: 4941–4947.
54.
LeeuwenburghSCJoJWangH. Mineralization, biodegradation, and drug release behavior of gelatin/apatite composite microparticles for bone regeneration. Biomacromolecules2010; 11: 2653–2659.
55.
MengDDongLWenY. Effects of adding resorbable chitosan microparticles to calcium phosphate cements for bone regeneration. Mater Sci Eng C, Materials for biological applications2015; 47: 266–272.
56.
FeketeNGadelorgeMFurstD. Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. Cytotherapy2012; 14: 540–554.
57.
WashingtonC. Drug release from microdisperse systems – a critical review. Int J Pharmaceut1990; 58: 1–12.
58.
SiepmannJPeppasNA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev2001; 48: 139–157.
59.
ArifinDYLeeLYWangCH. Mathematical modeling and simulation of drug release from microparticles: implications to drug delivery systems. Adv Drug Deliv Rev2006; 58: 1274–1325.
60.
BurkhartJMVaudelMGambaryanS. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood2012; 120: e73–e82.
